Sunitinib in pediatric patients with advanced gastrointestinal stromal tumor: results from a phase I/II trial

BACKGROUND: Sunitinib is approved for treatment of adults with imatinib-resistant gastrointestinal stromal tumor (GIST) or imatinib intolerance. METHODS: This single-arm, multicenter, multinational phase I/II clinical trial (NCT01396148) enrolled eligible patients aged 6 to < 18 years with advanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Verschuur, Arnauld C., Bajčiová, Viera, Mascarenhas, Leo, Khosravan, Reza, Lin, Xun, Ingrosso, Antonella, Janeway, Katherine A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561985/
https://www.ncbi.nlm.nih.gov/pubmed/31006038
http://dx.doi.org/10.1007/s00280-019-03814-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561985/
https://www.ncbi.nlm.nih.gov/pubmed/31006038
http://dx.doi.org/10.1007/s00280-019-03814-5

Ejemplares similares